[Fever in the critically ill : To treat or not to treat]
- PMID: 30488315
- DOI: 10.1007/s00063-018-0507-x
[Fever in the critically ill : To treat or not to treat]
Abstract
Fever, arbitrarily defined as a core body temperature >38.3 °C, is present in 20-70 % of intensive care unit patients. Fever caused by infections is a physiologic reset of the thermostatic set-point and is associated with beneficial consequences, but may have negative sequelae with temperatures >39.5 °C. Fever of non-infectious and neurologic origin affects about 50 % of patients with elevated body temperature, presents as a pathologic loss of thermoregulation, and may be associated with untoward side effects at temperatures above 38.5-39.0 °C. Cooling can be achieved by physical and pharmacologic means. Evidence-based recommendations are not available. The indication for a cooling therapy can only be based on the physiologic reserve and the neurologic, hemodynamic, and respiratory state. The temperature should be lowered to the normothermic range. Hyperthermia syndromes require immediate physical cooling (and dantrolen when indicated).
Fieber, arbiträr als zentrale Körpertemperatur von >38,3 °C definiert, tritt bei 20–70 % der Intensivpatienten auf. Bei Infektionen ist es eine physiologische Umstellung der Temperaturregulation mit günstigen Effekten, kann aber bei Temperaturen >39,5 °C negative Auswirkungen haben. Fieber nichtinfektiöser oder neurologischer Ursache betrifft etwa 50 % der Patienten mit erhöhter Körpertemperatur, ist ein pathologischer Verlust der Thermoregulation und kann bei Temperaturen über 38,5–39,0 °C zu negativen Effekten führen. Fiebersenkung kann physikalisch oder pharmakologisch erfolgen. Evidenzbasierte Empfehlungen sind nicht möglich. Die Indikation zur Kühlungstherapie wird individuell unter Berücksichtigung der Ursache, der physiologischen Reserve sowie der neurologischen, hämodynamischen bzw. respiratorischen Situation gestellt. Die Temperatur sollte nur bis in den normothermen Bereich abgesenkt werden. Hypertherme Syndrome erfordern sofortige physikalische Kühlung (und ggf. Gabe von Dantrolen).
Keywords: Cooling; Infectious fever; Non-infectious fever; Pyrexia; Temperature management.
Similar articles
-
Comparison of fever treatments in the critically ill: a pilot study.Am J Crit Care. 2001 Jul;10(4):276-80. Am J Crit Care. 2001. PMID: 11432215 Clinical Trial.
-
Clinical trial of a novel surface cooling system for fever control in neurocritical care patients.Crit Care Med. 2004 Dec;32(12):2508-15. doi: 10.1097/01.ccm.0000147441.39670.37. Crit Care Med. 2004. PMID: 15599159 Clinical Trial.
-
Therapeutic hypothermia and controlled normothermia in the intensive care unit: practical considerations, side effects, and cooling methods.Crit Care Med. 2009 Mar;37(3):1101-20. doi: 10.1097/CCM.0b013e3181962ad5. Crit Care Med. 2009. PMID: 19237924 Review.
-
Fever in the critically ill medical patient.Crit Care Med. 2009 Jul;37(7 Suppl):S273-8. doi: 10.1097/CCM.0b013e3181aa6117. Crit Care Med. 2009. PMID: 19535958 Review.
-
The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study.Surg Infect (Larchmt). 2005 Winter;6(4):369-75. doi: 10.1089/sur.2005.6.369. Surg Infect (Larchmt). 2005. PMID: 16433601 Clinical Trial.
Cited by
-
Long-term health effects of antipyretic drug use in the aging population: a systematic review.J Med Life. 2024 Sep;17(9):830-839. doi: 10.25122/jml-2024-0081. J Med Life. 2024. PMID: 39628966 Free PMC article.
References
Literatur
-
- Niven DJ, Leger C, Stelfox HT, Laupland KB (2012) Fever in the critically ill: a review of epidemiology, immunology, and management. J Intensive Care Med 27(5):290–297
-
- O’Grady NP, Barie PS, Bartlett JG, Bleck T, Carroll K, Kalil AC, Linden P, Maki DG, Nierman D, Pasculle W et al (2008) Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med 36(4):1330–1349
-
- Madden LK, Hill M, May TL, Human T, Guanci MM, Jacobi J, Moreda MV, Badjatia N (2017) The implementation of targeted temperature management: an evidence-based guideline from the neurocritical care society. Neurocrit Care 27(3):468–487
-
- Cariou A, Payen JF, Asehnoune K, Audibert G, Botte A, Brissaud O, Debaty G, Deltour S, Deye N, Engrand N et al (2018) Targeted temperature management in the ICU: Guidelines from a French expert panel. Anaesth Crit Care Pain Med 37:481–491
-
- Niven DJ, Laupland KB, Tabah A, Vesin A, Rello J, Koulenti D, Dimopoulos G, de Waele J, Timsit JF (2013) Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators’ survey. Crit Care 17(6):R289 - PMC
MeSH terms
LinkOut - more resources
Full Text Sources
Medical